These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6363990)

  • 1. Effect of phosphoramidon - a selective enkephalinase inhibitor - on nociception and behaviour.
    Rupreht J; Ukponmwan OE; Admiraal PV; Dzoljic MR
    Neurosci Lett; 1983 Nov; 41(3):331-5. PubMed ID: 6363990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REM sleep deprivation decreases the grooming and shaking behaviour induced by enkephalinase inhibitor or opiate withdrawal.
    Ukponmwan OE; vd Poel-Heisterkamp AL; Dzoljic MR
    Pharmacol Biochem Behav; 1985 Sep; 23(3):385-9. PubMed ID: 3901041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enkephalinase inhibition prevented tolerance to nitrous oxide analgesia in rats.
    Rupreht J; Ukponmwan OE; Dworacek B; Admiraal PV; Dzoljic MR
    Acta Anaesthesiol Scand; 1984 Dec; 28(6):617-620. PubMed ID: 6395608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enkephalinase inhibition suppresses naloxone-induced jumping in morphine-dependent mice.
    Dzoljic MR; Rademaker B; vd Poel-Heisterkamp AL; Ukponmwan OE; Haffmans J
    Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):222-8. PubMed ID: 3539055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive effect produced by intracerebroventricularly administered dynorphin A is potentiated by p-hydroxymercuribenzoate or phosphoramidon in the mouse formalin test.
    Tan-No K; Ohshima K; Taira A; Inoue M; Niijima F; Nakagawasai O; Tadano T; Nylander I; Silberring J; Terenius L; Kisara K
    Brain Res; 2001 Feb; 891(1-2):274-80. PubMed ID: 11164832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REM sleep deprivation decreases the antinociceptive property of enkephalinase-inhibition, morphine and cold-water-swim.
    Ukponmwan OE; Rupreht J; Dzoljic MR
    Gen Pharmacol; 1984; 15(3):255-8. PubMed ID: 6376276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal ERK2 activation through δ2-opioid receptors contributes to nociceptive behavior induced by intrathecal injection of leucine-enkephalin.
    Komatsu T; Katsuyama S; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
    Peptides; 2014 Apr; 54():131-9. PubMed ID: 24480726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analgesic effect of enkephalinase inhibition is modulated by monoamine oxidase-B and REM sleep deprivations.
    Ukponmwan OE; Rupreht J; Dzoljic M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):376-9. PubMed ID: 3090452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enkephalinase inhibition antagonizes the increased susceptibility to seizure induced by REM sleep deprivation.
    Ukponmwan OE; Dzoljic MR
    Psychopharmacology (Berl); 1984; 83(3):229-32. PubMed ID: 6433386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH- and time-dependent inhibition of rat kidney neutral endoprotease 24.11 by thiorphan and phosphoramidon.
    Jeng AY; Ansell J; Erion MD
    Life Sci; 1989; 45(22):2109-14. PubMed ID: 2601566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enkephalinase: selective peptide inhibitors.
    Hudgin RL; Charleson SE; Zimmerman M; Mumford R; Wood PL
    Life Sci; 1981 Dec; 29(25):2593-601. PubMed ID: 7033704
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of enkephalinase inhibitor on endothelin-1 induced bronchoconstriction in guinea pigs].
    Ohse H; Nomura A; Kameyama M; Ninomiya H; Saotome M; Endoh T; Hamada M; Watanabe A; Uchida Y; Hasegawa S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1063-71. PubMed ID: 1507681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone's influence on neurobehavioral development.
    Zagon IS; McLaughlin PJ
    Pharmacol Biochem Behav; 1985 Mar; 22(3):441-8. PubMed ID: 3991759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of enkephalinase inhibitors: animal and human studies.
    Ehrenpreis S
    Acupunct Electrother Res; 1985; 10(3):203-8. PubMed ID: 2866674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoramidon potentiates the increase in lung resistance mediated by tachykinins in guinea pigs.
    Thompson JE; Sheppard D
    Am Rev Respir Dis; 1988 Feb; 137(2):337-40. PubMed ID: 2449105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E; Barbot L; Regoli D; Couture R
    Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. III. Inactivation of CCK-8 by a phosphoramidon-sensitive endopeptidase.
    Deschodt-Lanckman M; Koulischer D; Przedborski S; Lauwereys M
    Peptides; 1984; 5(3):649-51. PubMed ID: 6089150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enkephalinase inhibitor potentiates substance P- and capsaicin-induced bronchial smooth muscle contractions in humans.
    Honda I; Kohrogi H; Yamaguchi T; Ando M; Araki S
    Am Rev Respir Dis; 1991 Jun; 143(6):1416-8. PubMed ID: 1710881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enkephalinase inhibitors attenuate naloxone-precipitated withdrawal syndrome.
    Dzoljic MR
    NIDA Res Monogr; 1986; 75():575-8. PubMed ID: 3123978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats.
    Vemulapalli S; Watkins RW; Brown A; Cook J; Bernardino V; Chiu PJ
    Life Sci; 1993; 53(10):783-93. PubMed ID: 8355566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.